Brief Report: Does Menopause Transition Influence Viral Suppression and Adherence in Women Living With HIV?
Authors:
Open Access
- 3 January 2023
- journal article
- research article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 92 (5) , 399-404
Abstract
Background: Increasing numbers of women living with HIV transition through menopause. It is unclear whether this transition has an impact on treatment adherence, viral suppression, psychiatric comorbidities, or drug use. We aimed at examining adherence and viral suppression during the perimenopausal period and explored the influence of psychiatric comorbidities and active injection drug use (IDU). Setting: Retrospective Swiss HIV Cohort Study analysis from January 2010 to December 2018. Methods: We explored perimenopausal and postmenopausal trends of viral blips, low-level viremia, viral failure, adherence, psychiatric comorbidities, and IDU using interrupted time series models. Results: Rates of depression and psychiatric care increased during perimenopause before decreasing afterward. Negative treatment outcomes such as viral blips, low-level viremia, viral failure, and low adherence steadily declined while transitioning through menopause—this was also true for subgroups of women with depression, psychiatric treatment, and active IDU. Conclusions: Increased rates of depression and psychiatric care while transitioning through menopause do not result in lower rates of adherence or viral suppression in women living with HIV in Switzerland.Keywords
This publication has 27 references indexed in Scilit:
- 17β-Estradiol inhibits HIV-1 by inducing a complex formation between β-catenin and estrogen receptor α on the HIV promoter to suppress HIV transcriptionVirology, 2013
- Aging, Antiretrovirals, and Adherence: A Meta Analysis of Adherence among Older HIV-Infected IndividualsDrugs & Aging, 2013
- Estradiol Reduces Susceptibility of CD4+ T Cells and Macrophages to HIV-InfectionPLOS ONE, 2013
- Depressive symptoms are increased in the early perimenopausal stage in ethnically diverse human immunodeficiency virus–infected and human immunodeficiency virus–uninfected womenMenopause, 2012
- Executive summary of the Stages of Reproductive Aging Workshop +10: addressing the unfinished agenda of staging reproductive agingClimacteric, 2012
- Major depression during and after the menopausal transition: Study of Women's Health Across the Nation (SWAN)Psychological Medicine, 2011
- Treatment Responses in Antiretroviral Treatment–Naive Premenopausal and Postmenopausal HIV‐1–Infected Women: An Analysis from AIDS Clinical Trials Group StudiesClinical Infectious Diseases, 2009
- Menopause symptoms in women infected with HIV: Prevalence and associated factorsGynecological Endocrinology, 2007
- Risk for New Onset of Depression During the Menopausal TransitionArchives of General Psychiatry, 2006
- Effects of Depressive Symptoms and Mental Health Quality of Life on Use of Highly Active Antiretroviral Therapy Among HIV-Seropositive WomenJAIDS Journal of Acquired Immune Deficiency Syndromes, 2002